• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED ABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED ABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Cardiac Tamponade (2226)
Event Date 08/01/2020
Event Type  Injury  
Event Description
Per literature review, it was reported that a study was to investigate the utility of mapping the atrium and ventricle simultaneously with a high density 3d mapping system for ablation of accessory pathways (ap) with the rhythmia mapping system with the intellamap orion catheter from july 2015 to august 2020, 128 consecutive patients underwent an initial procedure of catheter ablation (ca) for an ap guided by a 3d mapping system.All ablation procedures were performed under deep sedation using propofol, dexmedetomidine, and pentazocine.The pentazocine.A dual chamber map was created using the rhythmia system and orion catheter.The potential reference for the 3d map was obtained from two different sites in the coronary sinus, and the maps were obtained from the orion catheter.The rhythmia system has a specific the maps were obtained from the orion catheter.Ablation was performed at the earliest activation site on the av annulus while considering the local potential under pacing from the right atrium or right ventricle.Considering the local potential under pacing from the right atrium or right ventricle.Ablation was performed using irrigation and non--irrigation catheters including blazer, intella nav mifi oi.Cardiac tamponade requiring pericardiocentesis was observed in one patient during the rv catheter insertion.An arrhythmia recurrence was observed in two patients in the single chamber map group and in one in the dual chamber map group and in one in the dual chamber map group.Mori, h., kawano, d., sumitomo, n., muraji, s., nabeshima, t., tsutsui, k.,.Matsumoto, k.(2021).Ultra-high density atrio-ventricular dual chamber mapping as a next generation tool for ablation of accessory pathways.Journal of cardiovascular electrophysiology, 32(7), 1877-1883.Doi:10.1111/jce.15070.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV MIFI OPEN-IRRIGATED ABLATION CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC DE COSTA RICA S.R.L.
302 parkway, global park
la aurora, heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key14632105
MDR Text Key293545006
Report Number2134265-2022-06555
Device Sequence Number1
Product Code OAD
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/09/2022
Initial Date FDA Received06/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
BLAZER II XP; INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER
Patient Outcome(s) Other;
-
-